SCHEMBL30288103

SCHEMBL30288103

COc1ccc(CNC(=O)NC2CC3(C2)CC(C(=O)NCC(C)(C)c2ccccn2)C3)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ SCN9A Q15858 2/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MCHR1 Q99705 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.40
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26764123 1.00 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1SCN9AALDH1A1
SCHEMBL24011549 0.90 SMN1; SMN2 (0.53) SMN1; SMN2RAB9ANPC1SCN9AALDH1A1
SCHEMBL26764148 0.85 SMN1; SMN2 (0.49) SMN1; SMN2RAB9ANPC1ALDH1A1L3MBTL1
SCHEMBL26764110 0.85 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1SCN9AALDH1A1
SCHEMBL30306645 0.85 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1SCN9AALDH1A1
SCHEMBL30288118 0.84 SMN1; SMN2 (0.48) SMN1; SMN2RAB9ANPC1ALDH1A1POLB
SCHEMBL30288102 0.84 SMN1; SMN2 (0.48) SMN1; SMN2RAB9ANPC1ALDH1A1POLB
SCHEMBL26764121 0.84 SMN1; SMN2 (0.48) SMN1; SMN2RAB9ANPC1ALDH1A1POLB
SCHEMBL26764105 0.84 SMN1; SMN2 (0.48) SMN1; SMN2RAB9ANPC1ALDH1A1POLB
SCHEMBL30288093 0.84 SMN1; SMN2 (0.46) SMN1; SMN2RAB9ANPC1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed
EP-4146640-A2 NAMPT MODULATORS Cytokinetics, Inc. (US) 2023-03-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT SMN1; SMN2 610/4885RAB9A 814/4885NPC1 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback